For maternal serological indicators, Tongprasert F and other researchers have identified maternal serum alpha fetoprotein (AFP), placental like growth factor (PlGF), inhibin-A, and other biomarkers as potentially effective in predicting fetal α-thalassemia major during the second trimester (57–60). This evidence concerns the gene AFP and beta thalassemia.